Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

被引：1
|
作者：
Watanabe, J.
Horiguchi, J.
Masuda, N.
Aogi, K.
Sato, R.
Tokudome, T.
Peck, R. A.
机构：
[1] Shizuoka Canc Ctr, Shizuoka, Japan
[2] Gunma Univ, Sch Med, Maebashi, Gunma 371, Japan
[3] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
[4] Natl Hosp Org Shikoku Canc Ctr, Eihme, Japan
[5] Bristol Myers Squibb KK, Tokyo, Japan
[6] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13095
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane
    Martin, M.
    Campone, M.
    Bondarenko, I
    Sakaeva, D.
    Krishnamurthy, S.
    Roman, L.
    Lebedeva, L.
    Vedovato, J-C
    Aapro, M.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1195 - 1202
  • [42] Phase II study of eribulin mesylate (E7389) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracycline, taxane, and capecitabine therapy
    Vahdat, L. T.
    Twelves, C.
    Allison, M. K.
    Cortes, J. A.
    Campone, M.
    Shuster, D. E.
    Wanders, J.
    Fang, F.
    Gurnani, R. D.
    Blum, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Phase Ib study of ramucirumab and irinotecan for metastatic gastric cancer previously treated with fluoropyrimidine with/without platina and taxane.
    Sagawa, Tamotsu
    Satake, Hironaga
    Fujikawa, Koshi
    Hatachi, Yukimasa
    Yasui, Hisateru
    Kotaka, Masahito
    Kato, Takeshi
    Tsuji, Akihito
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [44] Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer
    Keun Seok Lee
    In Hae Park
    Byung-Ho Nam
    Jungsil Ro
    Investigational New Drugs, 2013, 31 : 152 - 159
  • [45] Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer
    Lee, Keun Seok
    Park, In Hae
    Nam, Byung-Ho
    Ro, Jungsil
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (01) : 152 - 159
  • [46] Phase I study of capecitabine in combination with CPT-11 for metastatic breast cancer (MBC) pre-treated with anthracycline and taxanes
    Kashiwaba, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
    Burstein, Harold J.
    Elias, Anthony D.
    Rugo, Hope S.
    Cobleigh, Melody A.
    Wolff, Antonio C.
    Eisenberg, Peter D.
    Lehman, Mary
    Adams, Bonne J.
    Bello, Carlo L.
    DePrimo, Samuel E.
    Baum, Charles M.
    Miller, Kathy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) : 1810 - 1816
  • [48] Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer
    Kosmas, C
    Agelaki, S
    Giannakakis, T
    Mavroudis, D
    Kouroussis, C
    Kalbakis, K
    Papadouris, S
    Souglakos, J
    Malamos, N
    Georgoulias, V
    ONCOLOGY, 2002, 62 (02) : 103 - 109
  • [49] VINFLUNINE (VFL) PLUS CAPECITABINE (CAPE) FOR ADVANCED BREAST CANCER (ABC) PREVIOUSLY TREATED WITH OR RESISTANT TO ANTHRACYCLINE AND RESISTANT TO TAXANE : A PHASE 3 STUDY VERSUS CAPECITABINE
    Martin, M.
    Demidchik, Y.
    Bondarenko, I.
    Siedakov, I.
    Sakaeva, D.
    Krishnamurthy, S.
    Roman, L.
    Lebedeva, L.
    Mefti, F.
    Bachelot, T.
    Ponomarova, O.
    Delaloge, S.
    Lytvyn, I.
    Kupp, A.
    Karchmit, Y.
    Bougnoux, P.
    Campone, M.
    Aapro, M. S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [50] Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer
    S.-H. Lee
    J. Lee
    J. Park
    S. H. Park
    K.-E. Lee
    S. I. Lee
    E. Nam
    J. O. Park
    K. Kim
    C. W. Jung
    Y. S. Park
    S. S. Yoon
    W. K. Kang
    M. H. Lee
    K. Park
    Y.-H. Im
    Medical Oncology, 2004, 21 : 223 - 231
12345